Sherlock Biosciences have discovered a new thermostable Cas nuclease that enables real-time detection of RNA and or DNA targets, the company says in a press release. The new Cas nuclease will have broad implications for the SHERLOCK™ CRISPR-based method to detect and quantify specific genetic sequences that are already used for Covid-19 diagnosis.
The 62nd American Society of Hematology (ASH) annual meeting took place virtually last weekend (December 5-8, 2020). Register for free and check out the many poster presentations and oral abstracts in the Gene Editing, Therapy and Transfer sessions.